Brief: Orchestra Biomed Announces Presentations Highlighting Avim Therapy Potential Impact On Hypertensive Heart Disease And Heart Failure At Tht And Crt
03/03/2026 13:10
March 3 (Reuters) - Orchestra Biomed Holdings Inc OBIO.O: ORCHESTRA BIOMED ANNOUNCES PRESENTATIONS HIGHLIGHTING AVIM THERAPY POTENTIAL IMPACT ON HYPERTENSIVE HEART DISEASE AND HEART FAILURE AT THT AND CRT Source text: ID:nGNX7SV91 Further company coverage: OBIO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orchestra Biomed Holdings
See all newsBrief: Orchestra Biomed Announces Pricing Of Public Offering
Orchestra BioMed slides after starting equity offering
Brief: Orchestra Biomed Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Orchestra Biomed Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Orchestra BioMed Q2 revenue drops, net loss widens